Diagnostic accuracy and interobserver agreement of digital single-operator cholangioscopy for indeterminate biliary strictures - 17/11/21
on behalf of the
European Cholangioscopy Group
Abstract |
Background and Aims |
Digital single-operator cholangioscopy (d-SOC) with cholangioscopic biopsy sampling has shown promise in the evaluation of indeterminate biliary strictures. Some studies have suggested higher sensitivity for visual impression compared with biopsy sampling, although assessors were not blinded to previous investigations. We aimed to investigate the diagnostic accuracy and interobserver agreement (IOA) of d-SOC in the visual appraisal of biliary strictures when blinded to additional information.
Methods |
A multicenter, international cohort study was performed. Cholangioscopic videos in patients with a known final diagnosis were systematically scored. Pseudonymized videos were reviewed by 19 experts in 2 steps: blinded for patient history and investigations and unblinded.
Results |
Forty-four high-quality videos were reviewed of 19 benign and 25 malignant strictures. The sensitivity and specificity for the diagnosis of malignancy was 74.2% and 46.9% (blinded) and 72.7% and 62.5% (unblinded). Cholangioscopic certainty of a malignant diagnosis led to overdiagnosis (sensitivity, 90.6%; specificity, 33%), especially if no additional information was provided. The IOA for the presence of malignancy was fair for both assessments (Fleiss’ κ = .245 [blinded] and κ = .321 [unblended]). For individual visual features, the IOA ranged from slight to moderate for both assessments (κ = .059-.400 vs κ = .031-.452).
Conclusions |
This study showed low sensitivity and specificity for blinded and unblinded d-SOC video appraisal of indeterminate biliary strictures, with considerable interobserver variation. Although reaching a consensus on the optical features of biliary strictures remains important, optimizing visually directed biopsy sampling may be the most important role of cholangioscopy in biliary stricture assessment.
Le texte complet de cet article est disponible en PDF.Abbreviations : CI, d-SOC, IOA, PSC
Plan
| DISCLOSURE: Funding for PhD received for P.M.C.S from the European Cholangioscopy Group, which received an unrestricted educational grant from Boston Scientific Inc. In addition, the following authors disclosed financial relationships: A. Anderloni: Consultant for Boston Scientific, Medtronic, Olympus, and Storz. V. Cennamo: Consultant and speaker for and travel grants from Olympus Italia, Olympus Europe, Euromedical, and Novita. N. I. Church: Consultant for and speaker fees from Boston Scientific. M. T. Huggett: Speaker for Boston Scientific, Cook Medical, and Olympus. M. W. James: Lecturer for Boston Scientific and Cook Medical. D. Joshi: Consultant for Boston Scientific, Cook Medical, and TaeWoong Medical. W. Laleman: Consultant for Boston Scientific; co-chair of the Boston Scientific Chair in Therapeutic Biliopancreatic Endoscopy. J.-W. Poley: Consultant and speaker for and travel grants from Boston Scientific, Cook Medical, and Pentax. A. Repici: Consultant for Boston Scientific, Fujifilm, and Medtronic; research grants from Boston Scientific, Fujifilm, Medtronic, and ERBE. J. J. Vila: Consultant for Boston Scientific; lecturer for Cook Endoscopy and Olympus. T. Wong: Research grant and honoraria from Boston Scientific. M. J. Bruno: Consultant for Boston Scientific and Cook Medical; research support from Boston Scientific, Cook Medical, Pentax Medical, Mylan, ChiRoStim, and 3M. G. J. M. Webster: Consultant and speaker for Boston Scientific, Cook Endoscopy, and Pentax Medical. All other authors disclosed no financial relationships. |
|
| See CME section, p. 1135. |
Vol 94 - N° 6
P. 1059-1068 - décembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
